FMP
Protagenic Therapeutics, Inc.
PTIX
NASDAQ
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
1.03 USD
0.191 (18.54%)
About
ceo
Dr. Garo H. Armen Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.protagenic.comexchange
NASDAQ
Description
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
CIK
0001022899
ISIN
US74365N2027
CUSIP
74365N103
Address
149 Fifth Avenue
Phone
212 994 8200
Country
US
Employee
1
IPO Date
Apr 27, 2021
Summary
CIK
0001022899
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
74365N103
ISIN
US74365N2027
Country
US
Price
1.03
Beta
0.28
Volume Avg.
10.08k
Market Cap
4.6M
Shares
-
52-Week
0.5-1.98
DCF
0.3
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.71
P/B
-
Website
https://www.protagenic.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PTIX News
It looks like there's no news available.
